Bluejay Diagnostics Inc (BJDX) Stock Price, Quote & News

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices

Sector: Healthcare

Phone: 844 327 7078

Website: bluejaydx.com

Address:

360 Massachusetts Avenue, Suite 203, Acton, United States

CEOBuysDisclosures May. 18 at 11:25 PM

$BJDX CEO purchased 12,500 shares at $2.00 for a total of $25,000. Dey Indranil now owns 12,649 shares. https://ceo-buys.com

0 · Reply

Jj1369 May. 18 at 8:11 PM

$BJDX $3.75 to $1.75 one of the easiest shorts I’ve held. Going lower sub $1.00 for another RS Scam shell co with no product and patent expiring before they’ll even ever see the market

0 · Reply

Jj1369 May. 18 at 2:50 PM

$BJDX NEW ALL TIME LOWS BEARISH IS AN UNDERSTATEMENT

0 · Reply

Jj1369 May. 18 at 1:52 PM

$BJDX COMPLETE AND UTTER SCAM GOING TO ZERO

0 · Reply

Jj1369 May. 18 at 1:43 PM

$BJDX GOING TO ZERO!! SCAM NEIL DEY SHOULD BE IN PRISON OR GIVEN THE DEATH PENALTY. DUDE IS AN OUTRIGHT SCAM ARTIST

0 · Reply

Jj1369 May. 15 at 11:28 PM

$BJDX ALL TIME LOWS NOT A BUYER ON PLANET EARTH WANTS THIS SCAM. HOLDING MY SHORT TO $0.30

0 · Reply

Jj1369 May. 15 at 5:02 PM

$BJDX RSI going back to oversold sub 30. This is heading under $1.00 scam co short it to zero

1 · Reply

Jj1369 May. 15 at 2:07 PM

$BJDX RIP new all time lows

0 · Reply

Jj1369 May. 14 at 6:17 PM

$BJDX RIP to this scam Gapping down any day. Millions of warrants coming.

0 · Reply

OfficialStocktwitsUser May. 11 at 6:50 PM

$BJDX RSI: 38.49, MACD: -0.0509 Vol: 0.08, MA20: 1.89, MA50: 1.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

2026-04-07T10:45:34.000Z - 6 weeks ago

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

Apr 7, 2026, 6:30 AM EDT - 6 weeks ago

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Mar 12, 2026, 6:30 AM EDT - 2 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

2026-03-11T13:35:11.000Z - 2 months ago

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

Mar 11, 2026, 9:29 AM EDT - 2 months ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

2026-03-06T11:41:51.000Z - 2 months ago

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

Feb 20, 2026, 6:30 AM EST - 3 months ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

2026-02-17T11:45:15.000Z - 3 months ago

Bluejay Diagnostics enrolls 545 patients in SYMON II study

Feb 17, 2026, 6:30 AM EST - 3 months ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

2026-01-29T00:50:10.000Z - 3 months ago

Bluejay Diagnostics Inc trading halted, news pending

2026-01-27T13:10:41.000Z - 4 months ago

Bluejay Diagnostics announces 1-for-4 reverse stock split

2025-12-29T12:05:14.000Z - 5 months ago

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

Dec 29, 2025, 7:00 AM EST - 5 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

2025-11-10T12:55:58.000Z - 6 months ago

Bluejay Diagnostics provides Q3 corporate update

2025-10-23T21:05:24.000Z - 7 months ago

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

Oct 10, 2025, 5:16 PM EDT - 7 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2025-10-09T19:20:15.000Z - 7 months ago

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

Oct 9, 2025, 3:15 PM EDT - 7 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

2025-10-09T12:11:30.000Z - 7 months ago

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

2025-10-09T10:35:27.000Z - 7 months ago

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Oct 9, 2025, 6:30 AM EDT - 7 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Aug 7, 2025, 6:30 PM EDT - 10 months ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

2025-06-03T20:20:12.000Z - 1 year ago

Bluejay Diagnostics provides corporate update, reduces headcount to five

Jun 3, 2025, 4:05 PM EDT - 1 year ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

2025-04-29T21:35:15.000Z - 1 year ago

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

2025-04-15T11:11:20.000Z - 1 year ago

Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

2024-11-16T00:50:13.000Z - 1 year ago

Bluejay Diagnostics Inc trading halted, news pending

2024-11-13T22:20:26.000Z - 1 year ago

Bluejay Diagnostics announces 1-for-50 reverse stock split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Jun 28, 2024, 11:32 AM EDT - 2 years ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

2024-06-27T13:01:26.000Z - 2 years ago

Bluejay Diagnostics announces pricing of $8.75M underwritten public offering

Jun 26, 2024, 8:00 AM EDT - 2 years ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Nov 9, 2022, 8:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Aug 30, 2022, 4:05 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 16, 2022, 7:30 AM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Jul 27, 2022, 7:30 AM EDT - 4 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 26, 2022, 4:30 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Apr 20, 2022, 4:10 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Mar 28, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 24, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 10, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 13, 2022, 11:29 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 5, 2022, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Dec 16, 2021, 9:11 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

CEOBuysDisclosures May. 18 at 11:25 PM

$BJDX CEO purchased 12,500 shares at $2.00 for a total of $25,000. Dey Indranil now owns 12,649 shares. https://ceo-buys.com

0 · Reply

Jj1369 May. 18 at 8:11 PM

$BJDX $3.75 to $1.75 one of the easiest shorts I’ve held. Going lower sub $1.00 for another RS Scam shell co with no product and patent expiring before they’ll even ever see the market

0 · Reply

Jj1369 May. 18 at 2:50 PM

$BJDX NEW ALL TIME LOWS BEARISH IS AN UNDERSTATEMENT

0 · Reply

Jj1369 May. 18 at 1:52 PM

$BJDX COMPLETE AND UTTER SCAM GOING TO ZERO

0 · Reply

Jj1369 May. 18 at 1:43 PM

$BJDX GOING TO ZERO!! SCAM NEIL DEY SHOULD BE IN PRISON OR GIVEN THE DEATH PENALTY. DUDE IS AN OUTRIGHT SCAM ARTIST

0 · Reply

Jj1369 May. 15 at 11:28 PM

$BJDX ALL TIME LOWS NOT A BUYER ON PLANET EARTH WANTS THIS SCAM. HOLDING MY SHORT TO $0.30

0 · Reply

Jj1369 May. 15 at 5:02 PM

$BJDX RSI going back to oversold sub 30. This is heading under $1.00 scam co short it to zero

1 · Reply

Jj1369 May. 15 at 2:07 PM

$BJDX RIP new all time lows

0 · Reply

Jj1369 May. 14 at 6:17 PM

$BJDX RIP to this scam Gapping down any day. Millions of warrants coming.

0 · Reply

OfficialStocktwitsUser May. 11 at 6:50 PM

0 · Reply

Jj1369 May. 11 at 3:26 PM

$BJDX BEARISH RIP to this scam!

0 · Reply

Jj1369 May. 11 at 1:44 PM

$BJDX NOT GOING TO SEE $2.00 UNTIL THE NEXT RS SO BEARISH COMPLETE SCAM COMPANY

0 · Reply

Jj1369 May. 8 at 8:00 PM

$BJDX LOWEST ALL TIME CLOSING PRICE ON DAILY AND WEEKLY!!! GOING TO FUCKING ZERO! SHORT THIS TRASH!!!

0 · Reply

Jj1369 May. 8 at 3:26 PM

$BJDX RIP to this scam! CEO is a complete fraud! Company is a worthless shell that will never have a product! They exist to steal capital for insiders! SCAM STOCK

0 · Reply

Jj1369 May. 7 at 5:02 PM

$BJDX REVERSE SPLIT COMING OFFERING COMING GOING TO ZERO!!!!

0 · Reply

Jj1369 May. 6 at 9:26 PM

$BJDX offering imminent. Going to pennyland! BJDX IS A SCAM

0 · Reply

StockDocOne May. 6 at 3:00 PM

$BJDX target $7. Don’t know if I will hang that long to see it but expecting a pop soon. The 20 day is grinding on the 50 day. Something has to give way soon. Up or down.

1 · Reply

StockDocOne May. 6 at 11:37 AM

$BJDX let’s go any day now.

0 · Reply

Jj1369 May. 5 at 7:58 PM

$BJDX NOBODY WANTS THIS SCAM!

0 · Reply

SPACEDAD May. 1 at 8:50 PM

$BJDX Popped up on my accumulation scanner. Definitely on watch for a potential break out. Could potentially short squeeze. No position currently.

1 · Reply

Jj1369 May. 1 at 6:27 PM

$BJDX pump and dump scam company! CEO is a fraud! This is going to get dumped! Millions of toxic warrants on the way. Reverse split again by eoy

0 · Reply

StockDocOne May. 1 at 4:21 PM

$BJDX been waiting patiently to see how this would react when the 20 DMA hit the 50. We are finally here today. Let’s see if it holds.

1 · Reply

Market Cap	1.78M
Revenue (ttm)	0.00
Net Income (ttm)	-6.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	20,300
Avg Vol	21,538
Day's Range	N/A - N/A
Shares Out	1.04M
Stochastic %K	31%
Beta	0.72
Analysts	Strong Buy
Price Target	$32.00